Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
572 News Items found
An MSK researcher points at a medical image
MSK Research Highlights, June 19, 2026

New MSK research investigates how a natural antifungal compound produced by helpful gut bacteria might help protect vulnerable patients; finds that a protein “fingerprint” in blood could predict dangerous clots in cancer patients; uncovers Americans’ changing relationship with dietary supplements; and reveals how NK cells respond to infections so quickly.
Lorenz Studer, Danwei Huangfu, Ting Zhou, Thomas Vierbuchen
MorPhiC: Inside the Ambitious Project To Understand the Function of Every Human Gene

MSK scientists are part of an international consortium working to determine the biological functions of the roughly 20,000 protein-coding genes in the human genome.
detail of a scientist holding up a slide
MSK Research Highlights, June 11, 2026

New MSK research decodes how mesothelioma evades immunotherapy; shows why a common kidney cancer treatment combination falls short; and supports a free, open-source AI-driven drug discovery initiative.
Christine Mayr
MSK Scientists Uncover RNA’s Hidden Role as Protein Chaperone

New MSK research shows the largely overlooked "tail" region of mRNAs helps ensure key regulatory proteins get folded correctly — a fundamentally new understanding of their role.
An MSK researcher at work in the lab
MSK Research Highlights, May 26, 2026

New MSK research provides structural insights into how cancer cells thwart targeted RAS therapies; uncovers promising combination therapies for a rare childhood brain tumor; uses organoids to provide important clues about what drives pancreatic cancer; takes aim at appendix cancer with new laboratory models; and a develops a new precision tool for targeting cancer's energy factory.
micrograph of a T cell
Successfully Treated AML Patients May Hold the Key to New CAR T Cell Therapy

A team of researchers from MSK has developed a new type of CAR T cell therapy that shows promise against acute myeloid leukemia (AML) in preclinical models.
Caleb Lareau
Dr. Caleb Lareau Awarded 2026 Pershing Square Sohn Cancer Prize

MSK's Dr. Caleb Lareau was awarded a 2026 Pershing Square Sohn Cancer Prize, which is designed to empower early-career investigators to pursue bold, high-impact projects.
A researcher working in an MSK lab
MSK Research Highlights, April 27, 2026

New MSK research shows how pancreatic cancer cells organize themselves to fuel tumor growth; finds an antibody-drug conjugate shows efficacy in rare pediatric sarcoma; develops an AI tool could accelerate identification of disease-causing genetic variants; and builds quantum nanosensors for cancer blood tests.
a lab coat hangs in an MSK lab
Drs. Anna-Katerina Hadjantonakis and Robert Farese Elected to the American Academy of Arts and Sciences

Drs. Anna-Katerina Hadjantonakis and Robert Farese were elected to the 2026 class of the American Academy of Arts and Sciences.
Charles Sawyers presents at AACR 2026
AACR 2026 Research Roundup: The Latest Cancer Science Advances From MSK

Dozens of clinicians and scientists from across MSK presented the latest advances in cancer research at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17 to 22 in San Diego.